ABSTRACT Leishmania doovani, an intracellular protozoan, causes kala-azar by parasitizing the macrophages ofits mammalian host. Outbred NCS and CD-i mice develop immunity to this parasite. This immunity was demonstrable when supernatant fluids from cultured splenic lymphocytes were added to infected macrophages. Only the lympholdne preparations from infected mice showed significant leishmanicidal activity. Mice receiving multiple inocula-were more potent producers of leishmanicidal lymphokines than were those receiving single inocula. The expression of leishmanicidal activity in our system required continuous presence of the lympholdne preparation and was independent of trypsin-or neuraminidase-sensitive receptors ofthe macrophages. Light and electron microscopy revealed that, in the presence of lymphokines, macrophages appeared to be "activated," and intraceliular leishmanias developed specific subcellular lesions in the kdnetoplast-mitochondria. A time-course study showed that cultivation of the lymphocytes for 1/2 days completed the release of their leishmanicidal lympholdnes which were heat-labile molecules larger than 50,000 daltons.
Leishmanias are trypanosomatid protozoa whose amastigote stage parasitizes the mononuclear series ofthe reticuloendothelial system, resulting in leishmaniasis. In response to infection by different species, susceptible hosts manifest distinct clinical symptoms ranging from self-curing cutaneous lesions to an often-fatal visceral form (1) . Immunity of all species of animals is thought to be largely cell-mediated, but supporting evidence for this has been derived from investigations ofthe experimental cutaneous leishmaniases (2, 3) . The work of Skov and Twohy (4, 5) provided in vivo evidence for the importance of thymusderived lymphocytes in mouse immunity to visceral leishmania (Leishmania donovani).
We now provide evidence for the expression ofthis immunity in vitro by soluble lymphokine factors released by splenic lymphocytes derived from infected mice. Some properties of these factors and their effects on intracellular leishmanias in macrophages are characterized.
MATERIALS AND METHODS
All chemicals and medium components were purchased from Sigma and GIBCO, respectively.
Animals. Outbred NCS and CD-1 mice (at least 25 g in body weight) raised under conventional conditions at the Rockefeller University or Sloan-Kettering Cancer Research Center were used for the present study. Both strains of mice developed immunity to L. donovani, as indicated by examining the parasite burden during the course ofinfection. The number ofparasites in both liver and spleen increased during the initial 30 days and remained stable thereafter.
Parasites. Amastigotes ofL. donovani, Sudan-IS strain, were obtained from spleens of Syrian golden hamsters infected intracardially 1-2 months earlier. Isolated amastigotes were intact, viable, and free from host cell contamination (6, 7) .
Infection of Mice. Aliquots of the amastigote suspension in Hanks' balanced salt solution were injected intraveneously at 50 X 106 parasites per 0.2 ml per mouse through the tail vein. Control mice received injections ofsalt solution or material from normal hamster spleens subjected to the procedure used for the isolation ofamastigotes. Animals were killed 30 days after single inoculations or 1 week after four weekly injections.
Collection and Infection of Peritoneal Macrophages. Peritoneal macrophages ofcontrol and infected mice were infected in vitro with amastigotes. Peritoneal cells were isolated (6) and mixed with isolated amastigotes at 2°C in McCoy's medium with 10% heat-inactivated fetal bovine serum to yield 106 cells and 107 amastigotes per ml. The cell/parasite mixture was dispensed in 0. 1-ml aliquots into 15-mm2 flying glass coverslips (without overflow) in Petri dishes (nine coverslips per 9-cm dish). These cultures were incubated for about 3 hr at 37°C in 5% CO2/95% air to allow phagocytosis of the amastigotes by the macrophages and the adhesion of the latter to the surface. Prewarmed medium was then added (1 ml per coverslip) to the Petri dishes. Infected cultures were returned to the CO2 incubator until needed for further experiments.
Preparation of Splenic Lymphocytes and Lymphokines. Spleens from the same mice, which were killed for collection of peritoneal macrophages, were removed and processed for isolation of lymphocytes by centrifugation in a Ficoll/Hypaque gradient (8) . Lymphocytes isolated from individual spleens were suspended separately in McCoy's medium with 10% heat-inactivated fetal bovine serum at 3 X 106 cells per ml and cultured at 37C in 5% C02/95% air in tissue culture flasks or Petri dishes for up to 3 days with or without amastigote soluble antigens at 1 Ag of protein per ml. Soluble antigens were prepared by freeze-thawing freshly isolated amastigotes over a dry ice/acetone bath followed by centrifugation at 50,000 X g at 40C for 1 hr.
At the end of the incubation period, cultures were centrifuged (40C, 500 x g) for 10 min. Cell-free supernatant fluids were collected and filter-sterilized (pore size = 0.45 ,um). These lymphocyte culture supernatant fluids were referred to as lymphokine preparations. They were either kept separately according to individual spleen sources or pooled and were used Abbreviation: kDal, kilodalton. 7083
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after heat-inactivation (60'C for 30 min or 1000C for 10 min) or fractionated at 40C by Amicon Diaflo membrane discs (PM series 30, 50, 100 and 300) corresponding to 30, 50, 100, and 300 kilodalton (kDal) cut-offs in a stirred cell (model 52). In the fractionation experiments, macromolecular fractions were concentrated to at least 1/10th of the original volumes. In testing the activity of fractionated lymphokines, macromolecular fractions were reconstituted to their original volumes by the addition of the complete culture medium; the micromolecular fractions and heat-inactivated lymphokine preparations received an appropriate amount of heat-inactivated fetal bovine serum and vitamins (as a 10-fold concentrated stock solution), respectively, to compensate for the possible loss or inactivation of these components during the treatments.
Assays for Lymphokine-Mediated Leishmanicidal Activity. Mouse peritoneal macrophages infected in vitro with L. donovani amastigotes for 36-48 hr were exposed to various lymphokine preparations from homologous or allogeneic animals. This was done by replacing the culture medium of the infected macrophages with culture supernatant fluids of lymphocytes collected as described. Samples on coverslips were withdrawn in triplicate from each experimental series on day 1, 3, and 7 after incubation for microscopic quantitation of intracellular parasites (7, 9) . Briefly, coverslips with cells were dried by a stream of hot air or by vacuum aspiration, fixed in methanol, and stained with Giemsa. At least 100 macrophages were examined under an oil-immersion lens to determine the percentage ofinfected cells and the average number ofamastigotes per cell, from which percentage of day 7/day 1 infectivity and parasites/cell were calculated as criteria for determining leishmanicidal activity of lymphokines.
In separate experiments, lymphokine-mediated leishmanicidal activity was also determined under the following conditions: (i) Infected macrophages were treated at 370C with trypsin (1 mg/ml) or neuraminidase (100 milliunits/ml) in serumfree McCoy's medium for 30 min before exposure to lymphokine preparations (10) . (ii) Uninfected macrophages were first exposed to lymphokine preparations for up to 3 days with or without parasite soluble antigens; these macrophages then were infected with amastigotes and cultured in the absence of lymphokine preparations.
Electron Microscopy. Infected macrophages were plated on Thermanox plastic coverslips (Lux) and treated with lymphokine preparations as above. Coverslips with cells were processed in situ for electron microscopy as described (9) .
RESULTS

Lymphokine-Induced Morphological and Ultrastructural
Changes of Macrophages and. Their Intracellular Leishmanias. Macrophages infected with leishmanias and cultured for 7 days appeared as spindle-shaped cells, and most of them contained intact amastigotes (Fig. la) . When similarly infected macrophages were exposed to lymphokine preparations' from infected mice for 1 week, they became highly vacuolated and most of them were devoid of amastigotes (Fig. lb) . The intracellular events in the latter condition were examined further by electron microscopy. One day after the addition of the lymphokine preparations, no significant changes were noted, except for a few amastigotes which appeared to be degenerating (Fig. 2a) . Thereafter until day 7, subcellular structures of both macrophages and amastigotes changed considerably. Most striking in the macrophages was the occurrence of osmophilic cytoplasmic granules (Fig. 2b) . Amastigotes observed in these cells were mostly degenerative forms, of which many showed subcellular lesions such as swollen portions in the kinetoplastmitochondrial complexes. Lymphokine-Mediated Leishmanicidal Activity of Macrophages. In a period of 7 days in vitro, leishmanial amastigotes survived in mouse peritoneal macrophages, regardless of their source (from infected or uninfected mice) ( Table 1) . Infection of mice did not activate their macrophages in the peritoneal cavity to kill leishmanias in vitro. Within the same period of time, exposure of infected macrophages to lymphokine preparations reduced the number of intracellular parasites ( Table 2 ). The killing activity was dependent upon the sources ofthe lymphokine preparations: those from mice infected four times were more active than those from mice infected only once, but both were much more effective than those from uninfected mice. Prior treatment of uninfected macrophages with effective lymphokine preparations with or without soluble amastigote antigens for up to 3 days failed to confer leishmanicidal activity upon subsequent infections. Treatment ofinfected macrophages with trypsin or neuraminidase did not compromise their leishmanicidal activity in response to the lymphokine treatment.
Kinetics ofLeishmanicidal Lymphokine Production in Vitro. Lymphocytes appeared to release most of their leishmanicidal lymphokines within the first 32 hr in vitro (Table 3 ). In general, lymphocytes from mice given a single injection showed a more sustained release of less-potent leishmanicidal lymphokines than did those from mice given multiple injections. Lymphokines released at 32 hr sometimes were more potent than those released at 72 hr, suggesting completion of the release during the earlier period and inactivation ofleishmanicidal factors upon further incubation.
Characterization of Leishmanicidal Lympholdnes. Leishmanicidal activity of the lymphokine-preparations was sensitive to boiling but remained active after treatment at 600C for 30 min; they remained stable at -20'C for at least 6 months. Fractionation experiments with Amicon filters initially showed that the active leishmanicidal factors were larger than 30 kDal (Table  4) . In a subsequent series ofexperiments, a different lot oflymphokine preparation was further fractionated by using membranes of different cut-offs. Fractions smaller than 50 kDal had no leishmanicidal activity; those larger than this were more potent than the original unfractionated preparation. This seemed to suggest the presence of inhibitor(s) for the leishmancidal factors in the smaller fractions. Further fractionations of this lymphokine preparation by cut-offs at 100 or 300 kDal yielded distributions of leishmanicidal activity in all fractions, suggesting that the lymphokine preparation contained multiple leishmanicidal molecules with different sizes.
DISCUSSION
As shown in the present study, L. donovani infection of immunocompetent mice in vivo elicits the production of soluble splenic lymphocyte factors in vitro with amastigote-killing activity when added to infected macrophage cultures. Previously, concanavalin A-induced lymphokines (11) and granulocyte/ macrophage colony-stimulating factors (12) have been reported to produce such an effect in a similar host/parasite in vitro system for cutaneous leishmaniasis. However, these soluble mediators were not derived from lymphocytes of mice exposed to parasites. In our work, more potent leishmanicidal lymphokines were generated by mice repeatedly exposed to parasites than by those infected only once, indicative of acquired immunity expressed in vivo and demonstrated in vitro.
Our lymphokine preparations appear to have multiple leishmanicidal factors sensitive to boiling temperature and larger than 50 kDal. Because they are refractory to treatment at 60'C and because antileishmania antibodies are known not to affect intracellular amastigotes (13) (14) (15) , they are neither complement nor immunoglobulins. The loss of their leishmanicidal activity in culture (Table 3 ) and in the process of purification (unpublished data) indicates their lability to experimental manipulations. The size ofthese leishmanicidal factors (>50 kDal) differs from that ofgranulocyte/macrophage colony-stimulating factor (19) . Further investigations are needed to determine the possible identity of leishmanicidal factors in our lymphokine preparations to these and other well-known regulatory lym- 
